KTC
MD icon

Kistler-Tiffany Companies’s Pediatrix Medical MD Stock Holding History

Kistler-Tiffany Companies’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4
Closed – – 653
2014
Q2 		$0 Buy
+4
New +$235 ﹤0.01% 623

Other funds holding MD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Kistler-Tiffany Companies's MD Position: Q3 2014 in Review

Kistler-Tiffany Companies sold out of Pediatrix Medical (MD) in Q3 2014, closing a stake of 4 shares.

Kistler-Tiffany Companies first reported a position in MD in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 332 funds tracked by Wall St. Rank hold MD as of Q3 2014.

  • Kistler-Tiffany Companies reported no remaining Pediatrix Medical position as of Q3 2014 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 4 Pediatrix Medical shares in Q3 2014.
  • Kistler-Tiffany Companies first reported a position in Pediatrix Medical in Q2 2014 and held it in 1 quarter.
  • Kistler-Tiffany Companies's Pediatrix Medical position peaked at $0 in Q2 2014.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2014.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2014, filed 9 Oct 2014.